Teladoc Health, Inc.
TDOC
$6.36
-$0.25-3.78%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 613.85M | 642.27M | 626.44M | 631.90M | 629.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 613.85M | 642.27M | 626.44M | 631.90M | 629.37M |
| Cost of Revenue | 197.53M | 197.05M | 187.18M | 190.54M | 196.83M |
| Gross Profit | 416.32M | 445.22M | 439.26M | 441.36M | 432.54M |
| SG&A Expenses | 304.90M | 305.74M | 318.78M | 325.61M | 329.65M |
| Depreciation & Amortization | 92.29M | 94.84M | 88.37M | 93.00M | 87.87M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 662.57M | 669.24M | 661.90M | 677.94M | 684.31M |
| Operating Income | -48.73M | -26.97M | -35.46M | -46.04M | -54.94M |
| Income Before Tax | -60.84M | -33.62M | -50.22M | -40.42M | -111.27M |
| Income Tax Expenses | 3.00M | -8.48M | -715.00K | -7.76M | -18.26M |
| Earnings from Continuing Operations | -63.84M | -25.14M | -49.51M | -32.66M | -93.01M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -63.84M | -25.14M | -49.51M | -32.66M | -93.01M |
| EBIT | -48.73M | -26.97M | -35.46M | -46.04M | -54.94M |
| EBITDA | 5.48M | 28.67M | 10.68M | 2.68M | -8.96M |
| EPS Basic | -0.36 | -0.14 | -0.28 | -0.19 | -0.53 |
| Normalized Basic EPS | -0.17 | -0.09 | -0.12 | -0.11 | -0.16 |
| EPS Diluted | -0.36 | -0.14 | -0.28 | -0.19 | -0.53 |
| Normalized Diluted EPS | -0.17 | -0.09 | -0.12 | -0.11 | -0.16 |
| Average Basic Shares Outstanding | 179.12M | 177.83M | 176.93M | 175.92M | 174.15M |
| Average Diluted Shares Outstanding | 179.12M | 177.83M | 176.93M | 175.92M | 174.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |